Oct 8, 2026: Ultragenyx Community Webinar
On October 8, 2026, ASF and FAST hosted a webinar with Ultragenyx after the announcement that their phase 3 trial for GTX-102 (aspire) did not meet primary or key secondary endpoints. The webinar recording is now available: https://youtu.be/Jl43UtOVFm4